[go: up one dir, main page]

ZA938202B - Method of treating recurent miscarriage and improving the efficacy of assisted reproductive techniques using placental protein 14 - Google Patents

Method of treating recurent miscarriage and improving the efficacy of assisted reproductive techniques using placental protein 14

Info

Publication number
ZA938202B
ZA938202B ZA938202A ZA938202A ZA938202B ZA 938202 B ZA938202 B ZA 938202B ZA 938202 A ZA938202 A ZA 938202A ZA 938202 A ZA938202 A ZA 938202A ZA 938202 B ZA938202 B ZA 938202B
Authority
ZA
South Africa
Prior art keywords
recurent
miscarriage
efficacy
treating
improving
Prior art date
Application number
ZA938202A
Inventor
Anthony E Bolton
Tin-Chiu Li
Original Assignee
Intermune Life Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intermune Life Sciences Inc filed Critical Intermune Life Sciences Inc
Publication of ZA938202B publication Critical patent/ZA938202B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pregnancy & Childbirth (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
ZA938202A 1992-11-03 1993-11-03 Method of treating recurent miscarriage and improving the efficacy of assisted reproductive techniques using placental protein 14 ZA938202B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US97080792A 1992-11-03 1992-11-03

Publications (1)

Publication Number Publication Date
ZA938202B true ZA938202B (en) 1994-06-21

Family

ID=25517538

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA938202A ZA938202B (en) 1992-11-03 1993-11-03 Method of treating recurent miscarriage and improving the efficacy of assisted reproductive techniques using placental protein 14

Country Status (7)

Country Link
EP (1) EP0627931A1 (en)
JP (1) JPH07502755A (en)
AU (1) AU5332694A (en)
CA (1) CA2124694A1 (en)
IL (1) IL107469A0 (en)
WO (1) WO1994009805A2 (en)
ZA (1) ZA938202B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL111743A0 (en) * 1993-12-08 1995-01-24 Intermune Life Sciences Inc Recombinant genes expressing pp14
US5994148A (en) * 1997-06-23 1999-11-30 The Regents Of University Of California Method of predicting and enhancing success of IVF/ET pregnancy
US10143682B2 (en) 2014-10-28 2018-12-04 Koushi Yamaguchi Medicine for improving state of pregnancy, and use thereof
US11541040B2 (en) 2014-10-28 2023-01-03 Kouchi Yamaguchi Medicine for improving state of pregnancy, and use thereof
RU2585244C1 (en) * 2015-01-26 2016-05-27 Федеральное государственное бюджетное учреждение "Ивановский научно-исследовательский институт материнства и детства имени В.Н. Городкова" Минздрава России Method for prediction of recurrent threatening miscarriage

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5039521A (en) * 1989-01-11 1991-08-13 Hyal Pharmaceutical Corporation Immune cell proliferation inhibitors
CA2064544A1 (en) * 1991-06-28 1992-12-29 Anthony E. Bolton Immune cell proliferation inhibitors

Also Published As

Publication number Publication date
CA2124694A1 (en) 1994-05-11
AU5332694A (en) 1994-05-24
IL107469A0 (en) 1994-02-27
EP0627931A1 (en) 1994-12-14
WO1994009805A2 (en) 1994-05-11
JPH07502755A (en) 1995-03-23
WO1994009805A3 (en) 1994-05-26

Similar Documents

Publication Publication Date Title
GR3036347T3 (en) Compounds useful for treating allergic and inflammatory diseases.
EP0634930A4 (en) Compounds useful for treating allergic and inflammatory diseases.
IL102930A0 (en) Electrobiochemical analytical method and electrodes
HU9401580D0 (en) Method for the preparation and popification of alphia - interferon
GB9200218D0 (en) Method and apparatus for the identification of species
ZA908468B (en) Method for the prevention and treatment of bovine mastitis
IL105217A0 (en) Method and composition for treating acne
ZA938202B (en) Method of treating recurent miscarriage and improving the efficacy of assisted reproductive techniques using placental protein 14
PL308300A1 (en) Method of hydroxycarbonylating pentenic acids
HK1001868A1 (en) Chemically assisted protein annealing treatment
GB2267760B (en) Coil form and method for its use
EP0693544A3 (en) Process for the treatment and the recovery of crudes
ZA952797B (en) Method of treating auto-immune diseases using type one interferons
GB9202196D0 (en) Method of treatment
ZA939171B (en) Composition and process for treating tinplate
PL311659A1 (en) Method of treating animal bowels
KR950701012A (en) COMPOSITION AND PROCESS FOR TREATING METAL
PL299871A1 (en) Method of obtainingenamines in aqueous environment
GB9201391D0 (en) Method of treatment
GB9319897D0 (en) Method for the treatment and shaping of hair
GB9225262D0 (en) Recombinant antibody molecules and method
GB9218188D0 (en) Method of treatment
GB9226252D0 (en) Method of treatment
GB9223252D0 (en) Method of treatment
GB9202020D0 (en) Method of treatment